Skip to content

Clinical trials

Phase 2 Lysosomal Storage Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lysosomal Storage Diseases Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20113
20122
20142
20151
20181
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Not yet recruiting1
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Alexion Pharmaceuticals, Inc.2
McMaster University1
National Cancer Institute (NCI)1
Orchard Therapeutics1
Polaryx Therapeutics, Inc.1
Rocket Pharmaceuticals Inc.1
Shire1
The Hospital for Sick Children1
Ultragenyx Pharmaceutical Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lysosomal Storage Diseases13
Mucopolysaccharidosis IV3
Cholesterol Ester Storage Disease2
Metabolic Diseases2
Sandhoff Disease2
Wolman Disease2
Cardiomyopathies1
Cardiomyopathy, Hypertrophic1
Gangliosidoses, GM21
Genetic Diseases, Inborn1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.